Randomized, double-blind, placebo-controlled phase II study of single-agent oral talactoferrin in patients with locally advanced or metastatic non-small-cell lung cancer that progressed after chemotherapy.
暂无分享,去创建一个
S. Nag | J. Madhavan | P. Parikh | Junming Zhu | S. Patil | S. Advani | A. Bapna | A. Vaid | Yenyun Wang | A. Varadhachary | J. Sekhon | R. Malik | R. Digumarti | P. M. Ismail